US Patent 11752197 Macrophage stimulating 1 receptor (MST1R) variants and uses thereof

Is a

Patent

Patent attributes

Patent Applicant

Regeneron Pharmaceuticals

Current Assignee

Regeneron Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11752197

Patent Inventor Names

Julie Horowitz

Manuel Allen Revez Ferreira

Aris Baras

Date of Patent

September 12, 2023

Patent Application Number

16990744

Date Filed

August 11, 2020

Patent Citations

‌

US Patent 8933230 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compounds and application

‌

US Patent 9006252 Fused multicyclic compounds as protein kinase inhibitors

‌

US Patent 9089580 Formulation for regeneration of bone, cartilage, teeth, and periodontium and treatment of tumors and cysts

‌

US Patent 9103837 Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof

‌

US Patent 9128096 Methods for determining cancer resistance to histone deacetylase inhibitors

‌

US Patent 9186318 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof

‌

US Patent 9353415 Methods for functional analysis of high-throughput experimental data and gene groups identified therefrom

‌

US Patent 9403909 Anti-MST1R antibodies and uses thereof

...

Patent Primary Examiner

‌

Elizabeth C. Kemmerer

Methods of treating patients having inflammatory bowel disease (IBD) or primary sclerosing cholangitis (PSC) are provided herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11752197 Macrophage stimulating 1 receptor (MST1R) variants and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11752197 Macrophage stimulating 1 receptor (MST1R) variants and uses thereof